Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Operating Expenses | 3,480 | 13,508 | 2,320 | 0 |
| Operating Income | -3,480 | -13,508 | -2,320 | N/A |
| Other Income | -481 | -316 | -147 | 0 |
| Pre-tax Income | -3,961 | -13,824 | -2,467 | 0 |
| Net Income Continuous | -3,961 | -13,824 | -2,467 | N/A |
| Net Income | $-3,961 | $-13,824 | $-2,467 | $N/A |
| EPS Basic Total Ops | -374.80 | -2,201.60 | -230.80 | N/A |
| EPS Basic Continuous Ops | -155.33 | -601.04 | -115.97 | N/A |
| EPS Diluted Total Ops | -374.80 | -2,201.60 | -230.80 | N/A |
| EPS Diluted Continuous Ops | -155.33 | -601.04 | -115.97 | N/A |
| EBITDA(a) | $-3,478 | $-13,508 | $-2,320 | $N/A |